Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AbundRX vs Big Easy Weight Loss

AbundRX
Graded #192

Lower grade

vs+8.700000000000003
Big Easy Weight Loss
Graded #59

Higher grade

The verdict

Big Easy Weight Loss takes it — 75/100 to 66.3/100.

Big Easy Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Big Easy Weight Loss (joinbigeasy.com) is a New Orleans MD-run telehealth that ships compounded GLP-1 medication nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBig Easy Weight Loss +22
66
88
Dose & formulationBig Easy Weight Loss +8
64
72
Clinical oversightAbundRX +1
79
78
Labs & monitoringAbundRX +1
53
52
FulfillmentBig Easy Weight Loss +16
74
90
Contract termsEven
55
55
AbundRX · left barBig Easy Weight Loss · right bar

The numbers

MetricAbundRXBig Easy Weight Loss
WeighScore66.3/10075/100
GradeCC
Scorecard rank#192#59
Semaglutide$179/mo (compounded)$133/mo (all doses, compounded)
Tirzepatide$279/mo (compounded)$166/mo (all doses, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
AbundRX

Graded #192 · C

Strengths

  • Two clear compounded GLP-1 pathways with transparent pricing — semaglutide $179/mo and tirzepatide $279/mo
  • Fast, free shipping and a simple few-minute online health assessment
  • Provider-guided care connecting patients with licensed US clinicians
  • Publishes Terms, Privacy, and Refund policies

Where it loses points

  • Claims LegitScript certification in text but displays no verifiable seal or listing
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Compounding pharmacy not named; no HIPAA notice found; state availability not published
  • Heavily hedged marketing language ('may include', 'helping connect patients') — reads like a lead-generation platform
Big Easy Weight Loss

Graded #59 · C

Strengths

  • Low pricing: about 133 dollars per month for semaglutide, 166 for tirzepatide
  • Site states it serves all 50 states with a 2 to 3 day pharmacy turnaround
  • Names its partner compounding pharmacies and a Chief Medical Officer

Where it loses points

  • Priced as 10 to 12-week packages rather than a simple monthly fee
  • New-patient pricing is promotional and may rise on renewal

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard